MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-75-0013356
Biotree Formulations Private Limited
Biotree Formulations Private Limited - chemicals in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹10.55 Lakh
▼ 19% YoY
Net loss · FY 2025
₹15,560
Net margin -1.5%
EBITDA · FY 2025
-₹7,719
EBITDA margin -0.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Biotree Formulations Private Limited
Data last updated:
Biotree Formulations Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 09 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2021PTC365527.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Vipin Kaushik and Shalini Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Umashankar R Singh Panch Ratna Committee Rd 3 Singh State Kandivli East Mumbai, Maharashtra, India – 400101.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.55 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹15,560 (net margin -1.5%) and EBITDA of -₹7,719 (EBITDA margin -0.7%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.
Biotree Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-75-0013356).
Company Details of Biotree Formulations Private Limited
CIN U24299MH2021PTC365527
Registration Number 365527
Incorporation Date 09 August 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-75-0013356
Recognitions & Rankings of Biotree Formulations
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressUmashankar R Singh Panch Ratna Committee Rd 3 Singh State Kandivli East Mumbai, Maharashtra, India – 400101
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
Comprehensive company report
Biotree Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity
The main business activity of Biotree Formulations is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Biotree Formulations Private Limited
FY 2025 filings availableBiotree Formulations Private Limited reported revenue of ₹10.55 Lakh (down 19% YoY) for FY 2025.
Revenue · FY 2025
₹10.55 Lakh ▼ 19%
Net loss · FY 2025
₹15,560 margin -1.5%
EBITDA · FY 2025
-₹7,719 margin -0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 19%
3 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▼ 120%
3 years · compounded
▲ 49%
Revenue fell 19% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 38%. EBITDA fell 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2021-22 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | -₹7,719 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹15,560 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2021-22 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.7% | |
| Net Profit Margin | -1.5% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2021-22 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Biotree Formulations are in the company report.
: available in the company report
Board of Directors of Biotree Formulations Private Limited
Biotree Formulations has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vipin Kaushik | Director | 09 Aug 2021 | 5 Years 2 Months | Current |
| Shalini Singh | Director | 09 Aug 2021 | 5 Years 2 Months | Current |
| Ramagya Singh | Director | 07 Oct 2022 | 4 Years 0 Months | Current |
Peer Comparison
Biotree Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biotree Formulations Private Limited this company | ₹10.55 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Mumbai, Maharashtra, India |
| Cierge Formulations Private Limited | ₹10.53 Lakh (FY 2018) | •••• | •••• | -18.0% | •••• | Lucknow, Uttar Pradesh, India |
| Mediserve Devices Private Limited | ₹10.51 Lakh (FY 2025) | •••• | •••• | -20.0% | •••• | Delhi, India |
| Aglotus Pharmaceutical Private Limited | ₹10.46 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Lucknow, Uttar Pradesh, India |
Peers are the companies nearest to Biotree Formulations by revenue, above and below it, in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings
Biotree Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Biotree Formulations.
: available in the company report
Recent Activity
Biotree Formulations Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Ramagya Singh was appointed as Director on 07 Oct 2022.
AGM
Biotree Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biotree Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Ramagya Singh was appointed as Director.
Appointed
Shalini Singh was appointed as Director.
Appointed
Vipin Kaushik was appointed as Director.
Incorporation
09 Aug 2021
Biotree Formulations Private Limited was registered on 09 Aug 2021 with Roc Mumbai I & aged 5 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Biotree Formulations is an active private limited company based in Mumbai, Maharashtra, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 09 August 2021 (5+ years old) and is registered under CIN U24299MH2021PTC365527.
Biotree Formulations has 3 current directors:
- Vipin Kaushik - Director
- Shalini Singh - Director
- Ramagya Singh - Director
The latest financial statements of Biotree Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Biotree Formulations is U24299MH2021PTC365527. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biotree Formulations was incorporated on 09 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Biotree Formulations by revenue are Cierge Formulations Private Limited, Mediserve Devices Private Limited, Aglotus Pharmaceutical Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Ramagya Singh was appointed as Director on 07 Oct 2022. Shalini Singh was appointed as Director on 09 Aug 2021. Vipin Kaushik was appointed as Director on 09 Aug 2021.
Yes, Biotree Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-75-0013356).
The registered office of Biotree Formulations is at Umashankar R Singh Panch Ratna Committee Rd 3 Singh State Kandivli East Mumbai, Maharashtra, India – 400101.
Biotree Formulations operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Biotree Formulations can be reached at its registered office: Umashankar R Singh Panch Ratna Committee Rd 3 Singh State Kandivli East Mumbai, Maharashtra, India – 400101.